ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Interim Results Show Vaccine Lowers Breast Cancer Recurrence

December 30, 2011

In Brief: Walter To Retire, Search Starts For New DEA Deputy; Mary Fink Retires; NCCP Seeks Director

January 27, 1984

NCI, NIH Make Half-Hearted Pitch For Cancer Act Before Seemingly Uninterested Rogers Committee

March 10, 1978

NCI Lung Cancer Mutation Consortium: Screening For Mutations Can Focus Therapy

June 24, 2011

How Elite Institutions Were Affected By A Decade of Constricted Funding

October 31, 2014

Drug Development Budget Cuts Force Early End To P388 Screening Contracts

January 9, 1987